Interleukin-13 inhibits nitric oxide production in human colonic mucosa

Hepato-Gastroenterology

Volumn 47, Issue 33, 2000, Pages 714-717

  Kolios, George ^a   Wright, Karen L ^a   Linehan, John D ^a   Robertson, Duncan AF ^b   Westwick, John ^a  

^a University of Bath   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

Colonic epithelial cell; HT 29 cells; Interleukin 13; Nitric oxide

Indexed keywords

ALPHA INTERFERON; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 13; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL LINE; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FLUOROMETRY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AGED; CELLS, CULTURED; COLON; FEMALE; HUMANS; INTERLEUKIN-13; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 0034131242     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. 1 Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.
2. 2 Nathan C, Qiao-wen X: Nitric oxide synthases: Roles, tolls, and controls. Cell 1994; 78:915-918.
3. 3 Nussler AK, Billiar TR: Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukocyte Biol 1993; 54:171-178.
4. 4 Morris SM, Billiar TR: New insights into the regulation of inducible nitric oxide synthase. Am J Physiol 1994; 266:E829-E839.
5. 5 Whittle BJR: Nitric oxide in gastrointestinal physiology and pathology. In: Johnson LR (Ed.), Physiology of the gastrointestinal tract. 3rd Edition. New York: Raven Press, 1994; 6:267-294.
6. 6 Middleton SJ, Shorthouse M, Hunter JO: Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993; 341:465-466.
7. 7 Lundberg JON, Hellstrom PM, Lundberg JM, Alving K: Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994; 344:1673-1674.
8. 8 Boughton-Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJR, Moncada S: Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342:338-340.
9. 9 Kolios G, Petoumenos C, Nakos A: Mediators of inflammation: Production and implication in inflammatory bowel disease. Hepatogastroenterology 1998; 45:1601-1609.
10. 10 Kolios G, Brown Z, Robson RL, Robertson DAF, Westwick J: Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br J Pharmacol 1995; 116:2866-2872.
11. 11 Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WF: Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111:871-885.
12. 12 Kolios G, Rooney N, Murphy CT, Robertson DAF, Westwick J: Expression of inducible nitric oxide synthase (iNOS) activity in human colon epithelial cells: Modulation by T-lymphocyte derived cytokines. Gut 1998; 43:56-63.
13. 13 Sartor RB: Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 1994; 106:533-539.
14. 14 Kucharzik T, Lugering N, Adolf M, Domschke W, Stoll R: Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease. Dig Dis Sci 1997; 42:805-812.
15. 15 De Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, De Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993; 151:6370-6381.
16. 16 Zurawski G, De Vries JE: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15:19-26.
17. 17 Marfaing-Koka A, Devergne O, Gorgone G, Portier A, Schall TJ, Galanaud P, Emilie D: Regulation of the production of the RANTES chemokine by endothelial cells: Synergistic induction by IFN-gamma plus TNF-α and inhibition by IL-4 and IL-13. J Immunol 1995; 154:1870-1878.
18. 18 Isaacs KL, Sartor RB, Haskill JS: Cytokine mRNA profiles in inflammatory bowel disease mucosa detected by PCR amplification. Gastroenterology 1992; 103:1587-1595.
19. 19 Niessner M, Volk BA: Altered Th1-Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101:428-435.
20. 20 Kucharzik T, Stoll R, Lugering N, Domschke W: Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 100:452-456.
21. 21 Radford-Smith D, McGowan I, Jewell DP: Th1 and Th2 gene expression in inflammatory bowel disease. Gastroenterology 1994; 106:A757.
22. 22 Radford-Smith D, Jewell DP: Cytokines and inflammatory bowel disease. Bailliere's Clinical Gastroenterology 1996; 10:151-164.
23. 23 Wright KL, Ward SG, Kolios G, Westwick J: Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J Biol Chem 1997; 272:12626-12633.
24. 24 Minty A, Chalon P, Derocq J-M, Dumont X, Guillemot J-C, Kaghad M, Labit C, Leplatois P, Liauzan P, Miloux B, et al: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362:248-250.
25. 25 Kolios G, Wright KL, Jordan NJ, Leithead BJ, Robertson DAF, Westwick J: C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: Differential effect of T-lymphocyte derived cytokines. Eur J Immunol 1999; 29:530-536.
26. 26 Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG: A flourometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993; 214:11-16.
27. 27 Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
28. 28 Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P, Gordon S: Interleukin-13 alters the activation state of murine macrophages in vitro: Comparison with interleukin-4 and interferon-gamma. Eur J Immunol 1994; 24:1441-1445.
29. 29 Doherty TM, Kastelein R, Menon S, Andrade S, Coffman RL: Modulation of murine macrophage function by IL-13. J Immunol 1993; 151:7151-7160.
30. 30 Saura M, Martinez-Dalmau R, Minty A, Perez-Sala D, Lamas S: Interleukin-13 inhibits inducible nitric oxide expression in human mesangial cells. Biochem J 1996; 313:641-646.
31. 31 Grisham MB: Oxidants and free radicals in inflammatory bowel disease. Lancet 1994; 344:859-861.
32. 32 Kitagawa H, Takeda F, Kohei H: Effect of endothelium derived relaxing factor on the gastric lesion induced by HCl in rats. J Pharmacol Exp Ther 1990; 253:1133-1137.
33. 33 Hutcheson I, Whittle BJR, Boughton-Smith NK: Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101:815-820.
34. 34 MacNaughton WK, Cirino G, Wallace JL: Endothelium relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 1989; 4589:1869-1876.
35. 35 Hartley MG, Hudson MJ, Swarbrick ET, Gent AE, Hellier MD, Grace RH: The rectal mucosa-associated microflora in patients with ulcerative colitis. J Med Microbiol 1992; 36:96-103.
36. 36 Kwon NS, Stuehr DJ, Nathan CF: Inhibition of tumour cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 1991; 174:761-767.
37. 37 Drapier JC, Hibbs JB: Murine cytotoxic activated macrophages inhibit aconitase in tumour cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest 1986; 78:790-797.
38. 38 Grisham MB, Ware K, Gilleland HE, Gilleland LB, Abell CL, Yamada T: Neutrophil-mediated nitrosamine formation: a role of nitric oxide in rats. Gastroenterology 1992; 103:1260-1266.
39. 39 MacNaughton WK: Nitric oxide-donating compounds stimulate electrolyte transport in the guinea pig intestine in vitro. Life Sci 1993; 53:585-593.
40. 40 Lichtman SN, Sartor RB: Examining the role of inflammatory cytokines in chronic inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1993; 16:239-240.
41. 41 Telford EAR, Watson MS, Aird HC, Perry J, Davison AJ: The DNA sequence of equine herpes virus 2. J Mol Biol 1995; 249:520-528.
42. 42 Croitoru K, Ernest PB: Leukocyes in the intestinal epithelium. An unusual immunological compartment revisited. Regional Immunol 1992; 4:63-69.
43. 43 Christ AD, Blumberg RS: The intestinal epithelial cell: immunological aspects. Springer Semin Immunopathol 1997; 18:449-461.